<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02622139</url>
  </required_header>
  <id_info>
    <org_study_id>252_15B</org_study_id>
    <nct_id>NCT02622139</nct_id>
  </id_info>
  <brief_title>Multispectral Optoacoustic Tomography (MSOT) for the Evaluation of Disease Activity in Inflammatory Bowel Diseases (IBD)</brief_title>
  <acronym>MSOT_IBD</acronym>
  <official_title>Monocentric, Prospective Interventional Study to Assess the Degree of Disease Activity With a Multispectral Optoacoustic Tomography (MSOT) Handheld Scanner in Patients With Crohn's Disease or Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>iThera Medical GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monocentric, prospective interventional study to assess the degree of disease activity with a
      multispectral optoacoustic tomography (MSOT) handheld scanner in patients with Crohn's
      disease or ulcerative colitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is designed as a pilot study to evaluate the usefulness of MSOT for the
      evaluation of disease activity in IBD patients. As current methods for the evaluation of
      intestinal inflammation in IBD have relevant restrictions, new, non-invasive, quantitative,
      and accurate modalities are urgently needed. In comparison to other techniques, MSOT provides
      relevant advantages such as non-invasive imaging, high spatial resolution (this is of special
      importance for the evaluation of the intestine, which can be only a few millimeters thick),
      and highly sensitive detection of specific molecules such as total hemoglobin or oxy-
      /deoxygenated hemoglobin. These advantages suggest MSOT as an outstanding technique for
      evaluating disease activity in IBD.

      The proposed study incorporates nearly no risk for participating patients and might provide
      relevant data for more a more in depth analysis of MSOT for IBD diagnosis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 2019</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of MSOT-data with clinical activity scores of IBD</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of MSOT-data with sonographic parameters</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">344</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <condition>IBD</condition>
  <arm_group>
    <arm_group_label>Multispectral Optoacoustic Tomography</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multispectral Optoacoustic Tomography (MSOT) for the evaluation of disease activity in inflammatory bowel diseases (IBD)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Multispectral Optoacoustic Tomography (MSOT)</intervention_name>
    <description>MSOT for the evaluation of disease activity in IBD patients</description>
    <arm_group_label>Multispectral Optoacoustic Tomography</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histological verified Crohn's disease or ulcerative colitis

          -  Age &gt; 18 years

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Mental retardation of the patient with restriction of general judgment and awareness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical Department 1, University of Erlangen-Nürnberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Knieling F, Neufert C, Hartmann A, Claussen J, Urich A, Egger C, Vetter M, Fischer S, Pfeifer L, Hagel A, Kielisch C, Görtz RS, Wildner D, Engel M, Röther J, Uter W, Siebler J, Atreya R, Rascher W, Strobel D, Neurath MF, Waldner MJ. Multispectral Optoacoustic Tomography for Assessment of Crohn's Disease Activity. N Engl J Med. 2017 Mar 30;376(13):1292-1294. doi: 10.1056/NEJMc1612455.</citation>
    <PMID>28355498</PMID>
  </results_reference>
  <results_reference>
    <citation>Waldner MJ, Knieling F, Egger C, Morscher S, Claussen J, Vetter M, Kielisch C, Fischer S, Pfeifer L, Hagel A, Goertz RS, Wildner D, Atreya R, Strobel D, Neurath MF. Multispectral Optoacoustic Tomography in Crohn's Disease: Noninvasive Imaging of Disease Activity. Gastroenterology. 2016 Aug;151(2):238-40. doi: 10.1053/j.gastro.2016.05.047. Epub 2016 Jun 3.</citation>
    <PMID>27269244</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 2, 2015</study_first_submitted>
  <study_first_submitted_qc>December 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2015</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Photoacoustics</keyword>
  <keyword>Optoacoustics</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

